Home003060 • KRX
add
Aprogen Biologics Inc
Previous close
₩700.00
Day range
₩687.00 - ₩708.00
Year range
₩600.00 - ₩1,780.00
Market cap
138.09B KRW
Avg Volume
392.72K
P/E ratio
-
Dividend yield
-
Market news
CNN
2 hours ago
S&P 500, Dow close out April in the red as economy contracts for first time since 2022
0.35%
0.15%
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 22.05B | -2.88% |
Operating expense | 13.64B | -62.33% |
Net income | -60.01B | 38.01% |
Net profit margin | -272.15 | 36.17% |
Earnings per share | — | — |
EBITDA | -17.21B | 51.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.32B | 281.15% |
Total assets | 590.98B | 0.27% |
Total liabilities | 212.29B | -3.81% |
Total equity | 378.69B | — |
Shares outstanding | 197.57M | — |
Price to book | 0.37 | — |
Return on assets | -9.15% | — |
Return on capital | -10.41% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -60.01B | 38.01% |
Cash from operations | -8.62B | -45.40% |
Cash from investing | -33.10B | -0.72% |
Cash from financing | 27.89B | -26.10% |
Net change in cash | -13.84B | -1,213.99% |
Free cash flow | -19.37B | -137.83% |
About
Founded
1960
Employees
425
